Cancer Stem Cells in Esophageal Cancer and Response to Therapy

Overview

Journal Cancer

Publisher Wiley

Specialty Oncology

Date 2018 Oct 29

PMID 30368777

Citations 4

Authors

Kazuto Harada

Melissa Pool Pizzi

Hideo Baba

Namita D Shanbhag

Shumei Song

Jaffer A Ajani

Affiliations

Soon will be listed here.

Citing Articles

Long Non-coding RNAs With and Efficacy in Preclinical Models of Esophageal Squamous Cell Carcinoma Which Act by a Non-microRNA Sponging Mechanism.

Weidle U, Birzele F Cancer Genomics Proteomics. 2022; 19(4):372-389.

PMID: 35732324 PMC: 9247874. DOI: 10.21873/cgp.20327.

Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.

Das P, Islam F, Smith R, Lam A Front Oncol. 2021; 10:598957.

PMID: 33665161 PMC: 7921694. DOI: 10.3389/fonc.2020.598957.

Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization.

Fanelli G, Naccarato A, Scatena C Front Oncol. 2020; 10:569.

PMID: 32391266 PMC: 7188928. DOI: 10.3389/fonc.2020.00569.

GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion.

Zhang W, Williams T, Bhagwath A, Hiermann J, Peacock C, Watkins D Lab Invest. 2019; 100(1):16-26.

PMID: 31292541 PMC: 6920545. DOI: 10.1038/s41374-019-0278-x.

References

Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

Ajani J, Wang X, Song S, Suzuki A, Taketa T, Sudo K . ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Mol Oncol. 2013; 8(1):142-9. PMC: 3946849. DOI: 10.1016/j.molonc.2013.10.007. View

Wang D, Plukker J, Coppes R . Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer. Semin Cancer Biol. 2017; 44:60-66. DOI: 10.1016/j.semcancer.2017.03.010. View

Wang Z, Da Silva T, Jin K, Han X, Ranganathan P, Zhu X . Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. Cancer Res. 2014; 74(21):6364-74. PMC: 4527315. DOI: 10.1158/0008-5472.CAN-14-2051. View

Batlle E, Clevers H . Cancer stem cells revisited. Nat Med. 2017; 23(10):1124-1134. DOI: 10.1038/nm.4409. View

Torres J, Watt F . Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3. Nat Cell Biol. 2008; 10(2):194-201. DOI: 10.1038/ncb1680. View

Shitara K, Doi T, Nagano O, Imamura C, Ozeki T, Ishii Y . Dose-escalation study for the targeting of CD44v cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205). Gastric Cancer. 2016; 20(2):341-349. DOI: 10.1007/s10120-016-0610-8. View

Zanconato F, Cordenonsi M, Piccolo S . YAP/TAZ at the Roots of Cancer. Cancer Cell. 2016; 29(6):783-803. PMC: 6186419. DOI: 10.1016/j.ccell.2016.05.005. View

Ajani J, DAmico T, Almhanna K, Bentrem D, Besh S, Chao J . Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw. 2015; 13(2):194-227. DOI: 10.6004/jnccn.2015.0028. View

10.

Wadhwa R, Wang X, Baladandayuthapani V, Liu B, Shiozaki H, Shimodaira Y . Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients. Br J Cancer. 2017; 117(5):648-655. PMC: 5572179. DOI: 10.1038/bjc.2017.225. View

11.

Sui Y, Jian X, Ma L, Xu G, Liao H, Liu Y . Prognostic value of cancer stem cell marker CD133 expression in esophageal carcinoma: A meta-analysis. Mol Clin Oncol. 2016; 4(1):77-82. PMC: 4727165. DOI: 10.3892/mco.2015.651. View

12.

Hoffmeyer K, Raggioli A, Rudloff S, Anton R, Hierholzer A, Del Valle I . Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. Science. 2012; 336(6088):1549-54. DOI: 10.1126/science.1218370. View

13.

Song S, Ajani J, Honjo S, Maru D, Chen Q, Scott A . Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties. Cancer Res. 2014; 74(15):4170-82. PMC: 4136429. DOI: 10.1158/0008-5472.CAN-13-3569. View

14.

Huang L, Lu Q, Han Y, Li Z, Zhang Z, Li X . ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells. Diagn Pathol. 2012; 7:180. PMC: 3542252. DOI: 10.1186/1746-1596-7-180. View

15.

Rassouli F, Matin M, Saeinasab M . Cancer stem cells in human digestive tract malignancies. Tumour Biol. 2015; 37(1):7-21. DOI: 10.1007/s13277-015-4155-y. View

16.

Song S, Xie M, Scott A, Jin J, Ma L, Dong X . A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma. Mol Cancer Ther. 2017; 17(2):443-454. PMC: 5805581. DOI: 10.1158/1535-7163.MCT-17-0560. View

17.

Smit J, Faber H, Niemantsverdriet M, Baanstra M, Bussink J, Hollema H . Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers. Radiother Oncol. 2013; 107(3):434-41. DOI: 10.1016/j.radonc.2013.03.027. View

18.

Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H . CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell. 2011; 19(3):387-400. DOI: 10.1016/j.ccr.2011.01.038. View

19.

. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017; 541(7636):169-175. PMC: 5651175. DOI: 10.1038/nature20805. View

20.

Sonbol M, Bekaii-Saab T . A clinical trial protocol paper discussing the BRIGHTER study. Future Oncol. 2018; 14(10):901-906. DOI: 10.2217/fon-2017-0406. View